International students face STEM OPT denials despite meeting requirements, often due to employment compliance issues. A recent case highlights the need for meticulous documentation and clear training ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

Korean biotechnology company, Nature Cell, is planning to open a stem cell facility in Baltimore, bringing 500 new jobs, the governor announced Tuesday. The 100,000 square foot manufacturing facility ...

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, ...

When you picture a scientist on television, who do you see? Too often, the answer is a man in a white lab coat, hunched over a microscope, or a stereotypical “mad genius” bent on world domination.

Stem reported fiscal 2025 second-quarter revenue of $38.37 million, up 12.9% year-over-year and beating estimates by $5.9 million. Gross profit margin for STEM rose to 33.36%, reflecting a positive ...

Spaceflight makes certain human stem cells age faster, a new study has found, furthering scientists’ understanding of the potential effects of space exploration on the human body. Stem cells are found ...

Knoepfler is STAT’s Lab Dish columnist and professor of cell biology and human anatomy at UC Davis School of Medicine. Japanese regulators just quietly gave researchers there a historic OK to generate ...

Florida is the latest state to sidestep the authority of the Food and Drug Administration by allowing patients to access certain stem-cell treatments that have not been rigorously evaluated and ...

Stem Inc. has executed a reverse stock split and major debt restructuring to improve its balance sheet and eliminate delisting risk. The company is pivoting from low-margin OEM hardware to ...

Torie Bosch is the First Opinion editor at STAT. Paul Knoepfler of the UC Davis School of Medicine has a bit of a hobby: keeping track of stem cell clinics operating in the U.S. He estimates that ...